Evidence map›Paper›PMID 28768205›Full record

ArticleCell reports2017

Impact of Alternative Splicing on the Human Proteome.

Yansheng Liu, Mar Gonzàlez-Porta, Sergio Santos, Alvis Brazma, John C Marioni, Ruedi Aebersold, Ashok R Venkitaraman, Vihandha O Wickramasinghe

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 195 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Impact of alternative splicing on Arabidopsis proteome.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Systematic identification of exercise-induced anti-aging processes involving intron retention.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Yansheng LiuDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Mar Gonzàlez-PortaEuropean Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.
Sergio SantosEuropean Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.
Alvis BrazmaEuropean Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.
John C MarioniEuropean Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland. Electronic address: aebersold@imsb.biol.ethz.ch.
Ashok R VenkitaramanThe Medical Research Council Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK. Electronic address: arv22@mrc-cu.cam.ac.uk.
Vihandha O WickramasingheThe Medical Research Council Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia. Electronic address: vi.wickramasinghe@petermac.org.
European Bioinformatics Institute · GBETH Zurich · CHPeter MacCallum Cancer Centre · AUUniversity of Cambridge · GB

Funding

Glycoprotein biomarkers for the early detection of aggressive prostate cancerU01CA152813 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2010 to 2021
$6.2M
Cancer Research UK 22231Medical Research Council 4050551988Medical Research Council G1001521Medical Research Council G1001522Medical Research Council MC_UU_12022/1Medical Research Council MC_UU_12022/8NCI NIH HHS U01 CA152813
6 · The paper itself

Abstract

Alternative splicing is a critical determinant of genome complexity and, by implication, is assumed to engender proteomic diversity. This notion has not been experimentally tested in a targeted, quantitative manner. Here, we have developed an integrative approach to ask whether perturbations in mRNA splicing patterns alter the composition of the proteome. We integrate RNA sequencing (RNA-seq) (to comprehensively report intron retention, differential transcript usage, and gene expression) with a data-independent acquisition (DIA) method, SWATH-MS (sequential window acquisition of all theoretical spectra-mass spectrometry), to capture an unbiased, quantitative snapshot of the impact of constitutive and alternative splicing events on the proteome. Whereas intron retention is accompanied by decreased protein abundance, alterations in differential transcript usage and gene expression alter protein abundance proportionate to transcript levels. Our findings illustrate how RNA splicing links isoform expression in the human transcriptome with proteomic diversity and provides a foundation for studying perturbations associated with human diseases.

Indexed as

Alternative SplicingFemaleHumansMaleProteomeRNA, MessengerProteomeRNA, Messengeralternative splicingproteomicsRNA

Identifiers

PMID28768205
PMCPMC5554779
OpenAlexW2741879909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.